excipient-optimization-platform
Developing complex biopharmaceuticals comes with significant formulation challenges, especially for stability and high-concentration delivery. Discover how innovative solutions can optimize your drug product development. Continue reading to learn more.
Menu
Current Situation
Typical Market Trends
Current Challenges and How They Are Solved
How Leukocare Can Support These Challenges
Value Provided to Customers
FAQ
The Evolving Landscape of Biopharmaceutical Formulation
The journey of a biologic drug from the lab to the patient is long and complex. For CMC and Drug Product Development leaders, navigating this path requires a deep understanding of the current market, its trends, and its challenges. This article looks at the current state of biopharmaceutical formulation, how challenges are being addressed, and how a strategic partner can make a difference.
Current Situation
The biopharmaceutical market is growing, with an expected value of nearly $600 billion by 2030. This growth is driven by an increase in chronic diseases, an aging population, and a greater acceptance of innovative therapies. [2] Developing these complex therapies is not easy. It can take over a decade and cost anywhere from $985 million to $2.6 billion to bring a new drug to market. [3, 4] A significant portion of these costs, around 13-17%, is tied to process development and manufacturing. [5]
Many biotech and pharmaceutical companies often outsource to manage these costs and complexities. [6, 7] The global formulation development outsourcing market is projected to reach $31.8 billion by 2027. [8, 9] Companies are increasingly turning to Contract Development and Manufacturing Organizations (CDMOs) for their expertise, especially in early-stage development. [8, 9, 25]
Typical Market Trends
Several trends are shaping the biopharmaceutical landscape. The rise of advanced modalities like viral vectors, RNA-based therapies, and antibody-drug conjugates (ADCs) presents new formulation challenges. [10] These molecules are often more complex and less stable than traditional biologics, requiring specialized knowledge to formulate correctly. [2, 11, 12, 19]
There is also a growing emphasis on personalized medicine and patient-centric drug delivery. [13, 14] This means we need formulations that people can give themselves, such as high-concentration, low-volume subcutaneous injections. [14] These formulations must be stable, have a manageable viscosity, and be compatible with delivery devices like pre-filled syringes or wearable injectors. [12, 14, 19]
The industry is also pushing for more efficient and data-driven development processes. [13] The use of artificial intelligence (AI) and predictive modeling is becoming more common to accelerate timelines and de-risk development. [15, 16, 17] These tools can help in predicting formulation stability, optimizing process parameters, and identifying potential issues early on.
Current Challenges and How They Are Solved
Even with all the progress, several challenges remain in biopharmaceutical formulation.
Instability and Degradation: Biologics are sensitive molecules prone to physical and chemical degradation, which can impact their safety and efficacy. [2, 11] A big challenge is stopping aggregation, that's when proteins clump up and can cause an immune reaction in patients. To fix this, formulation scientists do a lot of stress testing to figure out how things break down and pick the best ingredients and storage conditions. [2]
Complex Modalities: New treatments like viral vectors and mRNA vaccines have their own unique stability issues. [20, 21, 22] For example, mRNA is notoriously unstable and requires encapsulation in lipid nanoparticles (LNPs) for protection and delivery. [23] Viral vectors also require specific formulation conditions to maintain their integrity and infectivity. [21] Getting past these challenges often needs really deep technical know-how and special ways to analyze things. [24]
High Concentration Formulations: Making high-concentration formulations for under-the-skin shots is a big obstacle. [14] Lots of protein can make the liquid thick, making injections hard and painful. [14] Formulators are trying different ways to thin it out, like adjusting pH and salt levels, and using new ingredients.
Outsourcing and Partnerships: While outsourcing can give you access to experts and more capacity, it also has its own difficulties. [6] Companies need to find partners with the right technical capabilities and a collaborative mindset. [25, 9] A good partnership needs clear communication, shared expectations, and everyone being on the same page about the project's goals. [9, 25, 26]
How Leukocare Can Support These Challenges
Leukocare can help companies deal with these formulation challenges. We base our approach on a deep scientific understanding and a strong commitment to working together. We focus on creating strong, data-driven formulations that fit each molecule's unique needs and how it's meant to be used.
For companies working with advanced modalities, we offer in-depth knowledge of the unique stability challenges associated with viral vectors, RNA, and ADCs. Our teams have the specialized expertise to create stable and effective formulations for these complex products.
We also have a strong track record in developing high-concentration formulations for subcutaneous delivery. Our scientists know the techniques to handle thickness and keep these tough formulations stable.
Because data-driven development is so important, we use advanced analysis and predictive modeling to guide our formulation strategies. This helps us reduce development risks, speed things up, and deliver strong formulations ready for regulatory approval.
Value Provided to Customers
We want to be more than just a service provider; we aim to be a strategic partner. For a fast-moving biotech leader trying to get BLA approval quickly, we offer a clear, efficient path with a formulation built for regulatory success. For a small biotech without many internal resources, we give hands-on support and data-backed advice to push their program ahead.
For mid-sized and large pharma companies dealing with new treatments, we bring specialized knowledge and a collaborative approach to reduce risks and help their internal teams. For CDMOs wanting to offer full services, we can be a neutral, outside formulation partner, providing smooth project execution and scientific know-how.
Our real value is that we can solve tough formulation problems and give reliable, data-driven results our clients can trust.
FAQ
What are the biggest challenges in biologic drug formulation?
The main challenges are keeping complex and delicate molecules stable, stopping them from clumping and breaking down, and creating formulations that work for the intended way of giving the drug, especially for high-concentration shots under the skin. [12, 19]
Why is formulation development often outsourced?
Companies outsource formulation development to get specialized experts, new technologies, and extra capacity without having to spend a lot of money upfront. [7, 9, 25] This can help to speed things up and lower risks in the drug development process. [8, 9, 25]
How can I de-risk my formulation development?
To lower the risks in formulation development, you need to fully understand the molecule early on, do stress studies to see how it degrades, and use data to pick the best formulation. [27, 28] Partnering with an experienced CDMO can also provide valuable expertise and guidance. [25, 9]
What is the role of AI in formulation development?
AI and predictive modeling can speed up formulation development by looking at big sets of data to predict stability, find the best ingredients, and model how drugs are released. [15, 17] This can reduce the need for extensive experimental work and help to lower the development risk. [16]
What should I look for in a formulation development partner?
Look for a partner with the right technical skills, a good track record, and a willingness to work together. [25, 9] They should have the analytical tools you need and really understand the rules and regulations. [7] A good partner will work with you to understand exactly what you need and create a custom solution. [26]